这是因为在生物仿制领域有一个比成本更难以克服的障碍：法律诉讼。
That is because there is an obstacle to biosimilars even more formidable than cost: lawsuits.
金泰韩说，三星集团今年还会再成立一家合资公司生产生物仿制药。
Samsung Group may also set up another joint venture to make biosimilars this year, Kim said.
生物仿制制药是对生物技术制药进行的非专利仿制(尽管不是完全一致的复制)。
Biosimilars are generic impersonations (although not identical copies) of biotech drugs.
应用推荐